AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 13, 2025

Identifying a significant gap in the Ministry’s actions in addressing the funding and resource challenges in the premier mental health institutions, the Department-Related Parliamentary Standing Committee on Health and Family Welfare has recommended various measures including development of a comprehensive long-term strategic plan for mental healthcare, research and infrastructure development.

Development 113

Development Research Clinical Trials Clinical Trials 113

Bio Pharma Dive

FEBRUARY 13, 2025

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and a plan to develop drugs for brain function and health.

Development 200

Development Drugs 200

FDA Law Blog

FEBRUARY 13, 2025

By Lisa M. Baumhardt, Principal Medical Device Regulatory Expert FDA recently released its final guidance for Predetermined Change Control Plans (PCCPs) for Artificial Intelligence-Enabled Device Software Functions (AI-DSF). The final guidance hasnt changed much from the draft guidance with respect to the type of modifications FDA considers applicable for a PCCP and the required components of a PCCP (see our prior blog post on the draft guidance here ).

Manufacturing 71

Manufacturing Marketing Development Containment 71

Pharmaceutical Technology

FEBRUARY 13, 2025

AbbVie has entered a partnership and option-to-license agreement with Xilio for tumour-activated, antibody-based immunotherapies.

Antibody 162

Antibody Licensing Licensing 162

Advertisement

There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.

Trials

AuroBlog - Aurous Healthcare Clinical Trials blog

FEBRUARY 13, 2025

In the early hours of September 14 2021, three men parked in a quiet car park in the southern English market town of Abingdon-on-Thames. The men, returning from a night out, had pulled over to smoke heroin.

Drugs 147

Drugs Marketing Clinical Trials Clinical Trials 147

Bio Pharma Dive

FEBRUARY 13, 2025

Henry Gosebruch, Neumora’s CEO since 2023, will depart. Elsewhere, Biogen dropped two antisense drugs in a pipeline cull and Voyager hit a setback for its ALS gene therapy.

Gene Therapy 147

Gene Therapy Gene Drugs 147

Bio Pharma Dive

FEBRUARY 13, 2025

The French drugmaker said the vaccine it agreed to develop with Johnson & Johnson a year ago was “not sufficiently effective.

Vaccination 147

Vaccination Vaccine Development 147

Pharmaceutical Technology

FEBRUARY 13, 2025

SmartCella has secured exclusive rights to advance research around cell replacement therapies for the treatment of Parkinson's.

Research 147

Research 147

Pharma Times

FEBRUARY 13, 2025

Imaging agent to improve prostate cancer detection

131

131

Pharmaceutical Technology

FEBRUARY 13, 2025

Speaking publicly for the first time about the USAID freeze, WHO director-general Dr Tedros has asked the US to reconsider its position.

147

147

Advertiser: FourKites

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

Research

pharmaphorum

FEBRUARY 13, 2025

The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.

102

102

Pharmaceutical Technology

FEBRUARY 13, 2025

TriNetX has collaborated with Fujitsu to establish TriNetX Japan KK, a JV aimed at accelerating healthcare research and clinical trials.

Research 147

Research Clinical Trials Clinical Trials Trials 147

Pharma Times

FEBRUARY 13, 2025

Significant progress for hereditary angioedema condition

101

101

Pharmaceutical Technology

FEBRUARY 13, 2025

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab.

Drugs 147

Drugs Development 147

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g

Sales

pharmaphorum

FEBRUARY 13, 2025

Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder.

Drugs 78

Drugs 78

Pharmaceutical Commerce

FEBRUARY 13, 2025

The latest news for pharma industry insiders.

59

59

pharmaphorum

FEBRUARY 13, 2025

Another AI drug discovery venture has emerged from the Google DeepMind team, Latent Labs, with $50m in funding for its protein design platform.

Scientist 76

Scientist Drugs Protein 76

Pharmaceutical Commerce

FEBRUARY 13, 2025

In the fourth part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, explains the value of FDA guidance documents for manufacturers, along with the areas of CGT development that would benefit most from standardization.

Manufacturing 59

Manufacturing Development 59

pharmaphorum

FEBRUARY 13, 2025

Johnson & Johnson and Sanofi's vaccine for preventing invasive disease caused by E coli looks all but defunct after they abandon a phase 3 trial

Vaccination 74

Vaccination Vaccine Trials 74

Trialfacts

FEBRUARY 13, 2025

The post Typeform Test appeared first on Trialfacts.

52

52

pharmaphorum

FEBRUARY 13, 2025

Astellas has shored up the competitive profile of Izervay for eye disorder geographic atrophy, getting FDA approval for extended treatment.

FDA Approval 51

FDA Approval Drugs 51

Pharmaceutical Technology

FEBRUARY 13, 2025

Aardvarks lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Development 147

Development Drugs 147

pharmaphorum

FEBRUARY 13, 2025

Santhera has agreed pricing and reimbursement for its Duchenne muscular dystrophy drug Agamree with German health funds representing 90% of patients.

Drugs 49

Drugs 49

Rethinking Clinical Trials

FEBRUARY 13, 2025

The Health Care Systems Research Network (HCSRN) extended the early-bird registration deadline for its 2025 Annual Conference to February 28. The conference will be held from April 8 to 10 in St. Louis, Missouri. The theme of this year’s conference is “Optimizing Collaborations to Advance Health In a Dynamic Research Landscape.” The conference will provide networking opportunities to spur collaboration on research initiatives that improve health and healthcare for individuals a

Clinical Trials 130

Clinical Trials Clinical Trials Research Trials 130

pharmaphorum

FEBRUARY 13, 2025

In this podcast interview, learn about defining, building, and implementing strategies in the next wave of biopharma R&D. Stay informed and gain valuable insights from industry experts.

40

40

XTalks

FEBRUARY 13, 2025

MedTech M&As in 2025 featured an array of transactions from acquisitions that bolster interventional systems and digital testing capabilities to strategic moves in manufacturing and specialized equipment that underscore the sector’s commitment to advancing technology and operational excellence. Stay tuned for Xtalks monthly updates on M&As across the MedTech sector, with the next installment covering March 2025, as we continue to track and analyze emerging trends in MedTech M

Drug Delivery 102

Drug Delivery Manufacturing Production Clinical Research 102

Bio Pharma Dive

FEBRUARY 13, 2025

All but one Senate Republican voted for Kennedy, a controversial vaccine critic who used a crusade to "Make America Healthy Again" to win one of the most powerful jobs in Washington.

Vaccine 213

Vaccine Vaccination 213

Drug Patent Watch

FEBRUARY 13, 2025

The Unsung Heroes of Generic Drug Development: The Power of Partnerships As we navigate the complex landscape of pharmaceuticals, it's easy to overlook the crucial role that partnerships play in bringing affordable, life-saving medications to market. But the truth is, partnerships are the backbone of generic drug development, and their impact cannot be overstated.

Generic Drugs 83

Generic Drugs Development Drugs Marketing 83

XTalks

FEBRUARY 13, 2025

The findings shed light on patient adherence to long-term prophylaxis (LTP) treatments for hereditary angioedema (HAE) and highlight sebetralstats efficacy as an on-demand therapy. Dr. Raffi Tachdjian of UCLA presented a US commercial claims analysis revealing that nearly 40% of HAE patients initiating LTP experienced significant gaps in prescription refills over a 12-month period, with more than half discontinuing LTP altogether.

Trials 82

Trials Genetics Allergies Drugs 82

Drug Discovery World podcast

FEBRUARY 13, 2025

This is the latest episode of the free DDW narrated podcast, titled The continued evidence of AIs drug discovery value, which covers two articles written for DDW Volume 24 Issue 2, Spring 2023 of DDW. They are called: How generative AI could improve drug discovery and Can artificial intelligence help craft new medicines? Absci is a generative artificial intelligence (AI) drug creation company with goals of bringing better biologics to patients more quickly.

Drugs 52

Drugs Antibody Medicine 52

Pharmaceutical Technology

FEBRUARY 13, 2025

US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of Health (NIH), signalling headwinds in securing NIH grant funding for biopharmaceutical research and development (R7D).

Drugs 237

Drugs Development Research 237

XTalks

FEBRUARY 13, 2025

The FDA has granted approval to SpringWorks Therapeutics Gomekli (mirdametinib) for the treatment of adult and pediatric patients aged two years and older with neurofibromatosis type 1 (NF1). NF1 is a rare genetic disorder characterized by the development of tumors along nerves in the skin, brain and other parts of the body. According to SpringWorks, in the US, the disease affects approximately 100,000 children and adults.

FDA Approval 59

FDA Approval Genetics Clinical Trials Clinical Trials 59

Pharmaceutical Commerce

FEBRUARY 13, 2025

These taxes on goodswith the potential to take effect in weeks or monthswill vary by country, but rates could depend on regulations, industry subsidies, and other factors.

Regulation 52

Regulation 52

Rethinking Clinical Trials

FEBRUARY 13, 2025

Speaker Lillian Sung, MD, PhD Canada Research Chair in Pediatric Oncology Supportive Care Division of Haematology/Oncology Chief Clinical Data Scientist The Hospital for Sick Children Ontario, Canada Slides Keywords Cancer; Pediatrics; Cancer Symptoms; Symptom Control Key Points Symptom control in pediatric cancer patients is very poor; almost all children undergoing treatment for cancer will experience difficult symptoms, including fatigue, changes in hunger, pain, and n

Trials 100

Trials Research Clinical Trials Clinical Trials 100